The quality of our Covid19 related products is continuously validated by numerous of high impact papers.
Just a small overview to see that our SARS-CoV-2 products deliver meaningful results!
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Dear customer,
During this difficult time caused by COVID-19 (Coronavirus SARS-CoV-2), p&e is applying all the healthy measurements in order to protect our employees and to maintain the same high quality of products and service. If there are any changes due to the situation that could affect our work, you will be promptly informed. All inquiries and orders are still welcome.
Kind regards your team of
peptides&elephantsILB supports peptides&elephants enlarging its production site
The Business Promotion Bank of the Federal State of Brandenburg (ILB) supports peptides&elephants with enlarging its production site in Hennigsdorf. Read more »
NEW Product Launch - Custom Peptide Array Synthesis Services
Peptide arrays are powerful tools for the investigation of protein-protein and drug-protein interactions. Screening peptides for potentially active compounds with peptide arrays is a very convenient method for basic and applied research such as drug development. We describe here some of the principles and applications of peptide macroarrays. Read more »